Back to Search
Journal ArticleOpen Access

Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma

Author Affiliations
Queen's University Belfast, Belfast Health and Social Care Trust, Amgen (United States), Queens University
Published InEuropean Respiratory Journal
Year2016
Citations24

Abstract

Severe asthma represents a major unmet clinical need. Eosinophilic inflammation persists in the airways of many patients with uncontrolled asthma, despite high-dose inhaled corticosteroid therapy. Suppressors of cytokine signalling (SOCS) are a family of molecules involved in the regulation of cytokine signalling via inhibition of the Janus kinase-signal transducers and activators of transcription pathway. We examined SOCS expression in the airways of asthma patients and investigated whether this is associated with persistent eosinophilia.Healthy controls, mild/moderate asthmatics and severe asthmatics were studied. Whole genome expression profiling, quantitative PCR and immunohistochemical analysis were used to examine expression of SOCS1, SOCS2 and SOCS3 in bronchial biopsies. Bronchial epithelial cells were utilised to examine the role of SOCS1 in regulating interleukin (IL)-13 signalling in…
View at Publisher

BORR does not host full-text PDFs. The button above takes you to the original publisher.